ono 3307 has been researched along with Acute Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayakawa, T; Ishiguro, H; Kitagawa, M; Kondo, T; Nakae, Y; Sakai, Y; Shibata, T; Sobajima, H; Tanikawa, M | 1 |
| Calne, R; Hirano, T; Manabe, T; Printz, H; Steer, M; Tobe, T | 1 |
| Hirano, T; Manabe, T; Tobe, T | 3 |
| Hirano, T; Manabe, T; Nio, Y; Ohshio, G | 1 |
| Calne, R; Hirano, T; Manabe, T; Tobe, T | 1 |
| Ando, K; Hirano, T; Tobe, T; Yotsumoto, TM | 1 |
8 other study(ies) available for ono 3307 and Acute Disease
| Article | Year |
|---|---|
Effect of a new synthetic trypsin inhibitor on taurocholate-induced acute pancreatitis in rats.
Topics: Acute Disease; Animals; Dose-Response Relationship, Drug; Guanidines; Male; Pancreatitis; Rats; Rats, Wistar; Survival Rate; Taurocholic Acid; Trypsin Inhibitors | 1993 |
Protective effects of therapy with a protease and xanthine oxidase inhibitor in short form pancreatic biliary obstruction and ischemia in rats.
Topics: Acute Disease; Allopurinol; Animals; Ceruletide; Cholestasis, Extrahepatic; Drug Therapy, Combination; Guanidines; Ischemia; Male; Pancreas; Pancreatic Ducts; Pancreatitis; Rats; Rats, Wistar; Secretin; Serine Proteinase Inhibitors | 1993 |
Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis.
Topics: Acute Disease; Alprostadil; Amylases; Animals; Body Water; Cathepsin B; Ceruletide; Dinoprostone; Guanidines; L-Lactate Dehydrogenase; Lysosomes; Male; Microsomes; Pancreas; Pancreatitis; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Subcellular Fractions; Trypsinogen | 1992 |
Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007.
Topics: Acute Disease; Amylases; Animals; Body Water; Cathepsin B; Ceruletide; Edema; Gabexate; Guanidines; L-Lactate Dehydrogenase; Lysosomes; Male; Pancreas; Pancreatitis; Rats; Rats, Inbred Strains; Serine Proteinase Inhibitors | 1992 |
Protective effects of combined therapy with a protease inhibitor, ONO 3307, and a xanthine oxidase inhibitor, allopurinol on temporary ischaemic model of pancreatitis in rats.
Topics: Acute Disease; Allopurinol; Animals; Bile Ducts; Constriction; Drug Therapy, Combination; Guanidines; Ischemia; Male; Pancreas; Pancreatic Ducts; Pancreatitis; Rats; Rats, Wistar; Reperfusion; Serine Proteinase Inhibitors; Xanthine Oxidase | 1992 |
Effects of acute pancreatitis on hepatic secretion of lysosomal enzymes into bile and hepatic lysosomal fragility: protective effects of a new synthetic protease inhibitor, ONO 3307.
Topics: Acute Disease; Animals; Bile; Guanidines; Liver; Lysosomes; Male; Pancreatitis; Perfusion; Rats; Rats, Inbred Strains; Serine Proteinase Inhibitors | 1992 |
Impaired hepatic energy metabolism in rat acute pancreatitis: protective effects of prostaglandin E2 and synthetic protease inhibitor ONO 3307.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Acute Disease; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cathepsin B; Dinoprostone; Energy Metabolism; Guanidines; Hydroxybutyrates; Liver; Liver Diseases; Lysosomes; Malate Dehydrogenase; Male; Mitochondria, Liver; NAD; Pancreatitis; Protease Inhibitors; Rats; Rats, Inbred Strains | 1992 |
[Changes of acinar cells in the pancreato-biliary duct ligation with exocrine pancreatic stimulation model in rats; protective effects of a new potent protease inhibitor, ONO3307].
Topics: Acute Disease; Amylases; Animals; Bile Ducts; Cathepsin B; Disease Models, Animal; Guanidines; Ligation; Male; Pancreas; Pancreatic Ducts; Pancreatitis; Pressure; Rats; Rats, Inbred Strains; Serine Proteinase Inhibitors | 1991 |